openPR Logo
Press release

Global Biological Implants Market by Product, Application & End Users - 2023

12-30-2016 06:36 AM CET | Health & Medicine

Press release from: TMR - Research Reports

Global Biological Implants Market by Product, Application & End

Biological implants play a crucial role in routine clinical practices. These implants help in replacement or stabilization of injured tissue either permanently or transiently. Repairing non-unions, fixing fractures, lens prosthesis, total joint replacements, ocular implants, soft tissue repair, cochlear implants, and spinal reconstruction are some of the major applications of the biological implants. The major challenge faced with the use of biological implants id their ability to stimulate tissue regeneration which now a days is of greater scientific interest and constitutes a key expanding field. Another challenge for the biologic implants, rapidly entering the marketplace is to undergo FDA regulations and reporting of adverse events.

Request a PDF Brochure with Report Analysis:
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4618

Accidents on road and violence are a major cause of trauma which includes serious bone damage and internal bleeding. According to W.H.O. 3,400 deaths occur worldwide due to road accidents, and millions are injured who require medical attention. India ranks highest in the road accidents due to over populated roads and poor roads, and lack of traffic security. Accidents caused injuries lead to loss of appendage and serious fractures of extremities, cranial and spinal fractures. There is also a rise in two wheeler users in India who are more vulnerable to accidents. Sports like bike and car races, football, ice skiing, ice hockey, basketball, baseball, rugby, football, horse racing, and others which involve intense physical activities are also a major cause of joint replacement and trauma. The figures are more concerning in the lower age group. Around 3 million children under the age group of 14 are injured annually in sports activities.

The global biological implants market can be segmented based on origin, applications, and geography. Applications segment comprises cardiovascular, orthopedics, neurological, nephrological, dental, ophthalmic, urogenital and others. Origin of biological implants consists of allograft or xenograft. Geographically, North America is expected to be the largest regional market for biological implants due to an increase in orthopedic procedures, rise in incidence of obesity, rising incidences of road accidents and introduction of technologically advanced products. North America is a potential market for advanced products manufactured through innovation and transforming biomaterials technology. The region is anticipated to be followed by Europe owing to the rising demand for biological implants, especially in the orthopedic and cardiovascular applications.

According to the Centers for Disease Control and Prevention (CDC), high school athletes alone account for 2 million injuries, 50,000 doctor visits and 30,000 hospitalizations each year in the U.S. alone. Rise in youth sports injuries is fueled by an increase in overuse of the joints and repeated small trauma injuries. In addition, baby booming population in the U.S. is able to exercise under medical supervision; and may have to undergo surgeries such as hip and knee replacements, surgery for cartilage damage and others. The most common injuries include ankle sprain, plantar fasciitis, shoulder sprains and strains, rotator cuff tears and knee injuries. Thus, growing awareness about sports and exercises has led to rise in injuries and consequently a greater demand for biological implants.

Emerging economies in Asia Pacific and Latin America hold immense potential for the biological implants owing to their increasing population coupled with the presence of high unmet medical needs and rise in healthcare related customer expectations brought about by improvement in economic conditions. Rising per capita and disposable incomes have boosted the growth of the market in these regions. Additionally, the uncertain economic situation of the U.S. and Europe has compelled manufacturers to explore these potential emerging markets through acquisitions and collaborations.

Alphatec Spine, Inc., Allergan, Biomet, Inc, C.R. Bard, Globus Medical, Integra Lifescience Corporation, NuVasive, Regeneration Technologies, Inc., and Stryker Corporation are some of the key players in the global biological implants market.

Browse Full Research Report on Biological Implants Market:
http://www.transparencymarketresearch.com/biological-implants-market.html

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Browse market research blog:
https://tmrresearch.blogspot.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Biological Implants Market by Product, Application & End Users - 2023 here

News-ID: 403259 • Views:

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2024
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1.07 Billion by 2024
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million by 2024
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases


More Releases for Biological

Biological Control Market Projected to Witness Massive Growth - Koppert Biologic …
Biological Control Market Snapshot The Biological Control Market is projected to reach USD 9.7 billion by 2032, growing at a CAGR of 9.4% from 2025 to 2032. Coherent Market Insights proudly presents its latest Biological Control Market Research Report, delivering a detailed examination of the U.S. Biological Control Market outlook from 2025 to 2032. This comprehensive analysis provides strategic forecasts at both national and regional levels, addressing evolving supply networks, payer-provider collaboration,
Biological and Chemical Indicators Market - Beyond Measure: Biological and Chemi …
Newark, New Castle, USA: The "Biological and Chemical Indicators Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Biological and Chemical Indicators Market: https://www.growthplusreports.com/report/biological-and-chemical-indicators-market/8887 This latest report researches the
Biological APIs Market - Biological APIs: The Driving Force Behind Cutting-Edge …
Newark, New Castle, USA: The "Biological APIs Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Biological APIs Market: https://www.growthplusreports.com/report/biological-apis-market/8769 This latest report researches the industry structure, sales, revenue,
Human Immunoglobulin for Intravenous Injection Market demand and future scope wi …
A recent market research report added to repository of MR Accuracy Reports is an in-depth analysis of global Human Immunoglobulin for Intravenous Injection. On the basis of historic growth analysis and current scenario of Human Immunoglobulin for Intravenous Injection place, the report intends to offer actionable insights on global market growth projections. Authenticated data presented in report is based on findings of extensive primary and secondary research. Insights drawn from
Global Biological safety testing Market | Global Biological safety testing Indus …
Biologics are termed as those product that attained from living organism and feature a differentiate set of properties. The biologics want extreme safety from contamination thus biological safety testing is incorporate timely to make sure its safety quality and non-contamination of vaccines & biopharmaceuticals, along with comply with the bound rules applicable on it. A number of the foremost biological tests are sterility testing, bioburden testing, residual host contaminant detection
Meningococcal Infections Vaccine Market Insights, Forecast to 2025 : Sanofi-Past …
Researchmoz added Most up-to-date research on "Global Meningococcal Infections Vaccine Market Insights, Forecast to 2025" to its huge collection of research reports. This report studies the global market size of Meningococcal Infections Vaccine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Meningococcal Infections Vaccine in these regions. This research report categorizes the global Meningococcal Infections Vaccine market